IL7R 243InsPPCL was described in a B-ALL patient [36] and is one of a group of mutations in pediatric ALLs that activate IL7R by introducing unpaired cysteine residues in the membrane-proximal region of the receptor that cause constitutive dimerization [37]. This evidence concerns the gene IL7R and acute lymphoblastic leukemia.